Xencor, Inc Operating Lease Liability
Xencor, Inc (XNCR) had Operating Lease Liability of $65.21 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-05
- 2026-06-30: Operating Lease, Liability $65.21M.
- 2026-03-31: Operating Lease, Liability $66.63M.
- 2025-12-31: Operating Lease, Liability $68.00M.
- 2025-09-30: Operating Lease, Liability $69.27M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $65.21M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $66.63M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $68.00M 10-K · filed 2026-02-25 |
| 2025-09-30 | $69.27M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $67.93M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $67.82M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $68.35M 10-K · filed 2025-02-27 |
| 2024-09-30 | $68.67M 10-Q/A · filed 2025-02-24 |
| 2024-06-30 | $68.42M 10-Q/A · filed 2025-02-24 |
| 2024-03-31 | $68.89M 10-Q/A · filed 2025-02-24 |
| 2023-12-31 | $62.46M 10-K/A · filed 2025-02-24 |
| 2023-09-30 | $60.76M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $58.84M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $59.24M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $59.63M 10-K · filed 2023-02-27 |
| 2022-09-30 | $43.09M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $41.59M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $34.89M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $33.97M 10-K · filed 2022-02-24 |
| 2021-09-30 | $34.22M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $5.02M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $11.13M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $11.63M 10-K · filed 2021-02-24 |
| 2020-09-30 | $9.54M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $9.72M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $10.18M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $10.73M 10-K · filed 2020-02-25 |
| 2019-09-30 | $11.28M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $11.86M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $12.21M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |